Ilic D et al. – Given the limited number of randomised controlled trials published, and the varying quality of existing studies, it is not possible to support, or refute, the use of lycopene for the prevention or treatment of benign prostatic hyperplasia or prostate cancer. [more...]
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close